When ARS Technica writer Cyrus Fairvar decided to dive into his own genome to dig up hints about his risks for diseases – by ordering up SNP testing from two DTC companies – he found companies were willing to offer him risk assessments, but he also found those results were "complicated."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

DTC's Harms?

Working on It

23andMe's Data Deal

To Do Something

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.